Advances in the management of pancreatic ductal adenocarcinoma

被引：13
|
作者：
O'Kane, Grainne M. [1 ]
Ladak, Farah [2 ]
Gallinger, Steven [1 ]
机构：
[1] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Univ Alberta, Edmonton, AB, Canada
来源：
CANADIAN MEDICAL ASSOCIATION JOURNAL | 2021年 / 193卷 / 23期
关键词：
PHASE-II; ADJUVANT CHEMOTHERAPY; RANDOMIZED-TRIAL; CANCER RISK; GEMCITABINE; CHEMORADIOTHERAPY; SUBTYPES; SURVIVAL; THERAPY; REARRANGEMENTS;
D O I：
10.1503/cmaj.201450
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：E844 / E851
页数：8
相关论文
共 50 条
  • [41] Pancreatic ductal adenocarcinoma in 2017: Time to change the therapeutic algorithm?
    Crippa, Stefano
    Piccioli, Alessandra
    Guarneri, Giovanni
    Longo, Enrico
    Falconi, Massimo
    ENDOSCOPIC ULTRASOUND, 2017, 6 : S62 - S65
  • [42] Role of Surgery for Pancreatic Ductal Adenocarcinoma in the Era of Multidisciplinary Treatment
    Takagi, Kosei
    Umeda, Yuzo
    Yoshida, Ryuichi
    Fuji, Tomokazu
    Yasui, Kazuya
    Yagi, Takahito
    Fujiwara, Toshiyoshi
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (02)
  • [43] Induction FOLFIRINOX for patients with locally unresectable pancreatic ductal adenocarcinoma
    McIntyre, Caitlin A.
    Cohen, Noah A.
    Goldman, Debra A.
    Gonen, Mithat
    Sadot, Eran
    O'Reilly, Eileen M.
    Varghese, Anna M.
    Yu, Kenneth H.
    Balachandran, Vinod P.
    Soares, Kevin C.
    D'Angelica, Michael, I
    Drebin, Jeffrey A.
    Kingham, T. P.
    Allen, Peter J.
    Wei, Alice C.
    Jarnagin, William R.
    JOURNAL OF SURGICAL ONCOLOGY, 2022, 125 (03) : 425 - 436
  • [44] Initial pulmonary metastasis after pancreatectomy for pancreatic ductal adenocarcinoma
    Shimizu, Tetsunosuke
    Taniguchi, Kohei
    Asakuma, Mitsuhiro
    Komeda, Koji
    Inoue, Yoshihiro
    Lee, Sang-Woong
    Hirokawa, Fumitoshi
    Uchiyama, Kazuhisa
    SURGERY TODAY, 2020, 50 (04) : 413 - 418
  • [45] Pancreatic fibrosis, acinar atrophy and chronic inflammation in surgical specimens associated with survival in patients with resectable pancreatic ductal adenocarcinoma
    Korpela, Taija
    Ristimaki, Ari
    Udd, Marianne
    Vuorela, Tiina
    Mustonen, Harri
    Haglund, Caj
    Kylanpaa, Leena
    Seppanen, Hanna
    BMC CANCER, 2022, 22 (01)
  • [46] Pharmacotherapeutic Management of Pancreatic Ductal Adenocarcinoma: Current and Emerging Concepts
    Dietrich A. Ruess
    Kivanc Görgülü
    Sonja M. Wörmann
    Hana Algül
    Drugs & Aging, 2017, 34 : 331 - 357
  • [47] Hong Kong consensus recommendations on the management of pancreatic ductal adenocarcinoma
    Chan, Stephen L.
    Chiang, C. L.
    Chok, Kenneth S. H.
    Lee, A. S.
    Tang, Raymond S. Y.
    Lim, Fiona M. Y.
    Lee, K. F.
    Tai, Anna Y. P.
    Lee, Sarah W. M.
    Lo, Regina C. L.
    Chan, Anthony W. H.
    Mok, Francis P. T.
    HONG KONG MEDICAL JOURNAL, 2024, 30 (02) : 147 - 162
  • [48] Photodynamic Stromal Depletion in Pancreatic Ductal Adenocarcinoma
    Lintern, Nicole
    Smith, Andrew M.
    Jayne, David G.
    Khaled, Yazan S.
    CANCERS, 2023, 15 (16)
  • [49] Heterogeneity of KRAS Mutations in Pancreatic Ductal Adenocarcinoma
    Hashimoto, Daisuke
    Arima, Kota
    Yokoyama, Naomi
    Chikamoto, Akira
    Taki, Katsunobu
    Inoue, Risa
    Kaida, Takayoshi
    Higashi, Takaaki
    Nitta, Hidetoshi
    Ohmuraya, Masaki
    Hirota, Masahiko
    Beppu, Toru
    Baba, Hideo
    PANCREAS, 2016, 45 (08) : 1111 - 1114
  • [50] Repurposed Drugs in Pancreatic Ductal Adenocarcinoma An Update
    Ilmer, Matthias
    Westphalen, C. Benedikt
    Niess, Hanno
    D'Haese, Jan G.
    Angele, Martin K.
    Werner, Jens
    Renz, Bernhard W.
    CANCER JOURNAL, 2019, 25 (02) : 134 - 138
12345